SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-212537
Filing Date
2020-08-07
Accepted
2020-08-07 08:20:26
Documents
71
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d16842d10q.htm   iXBRL 10-Q 1957634
2 EX-31.1 d16842dex311.htm EX-31.1 10216
3 EX-31.2 d16842dex312.htm EX-31.2 10269
4 EX-32 d16842dex32.htm EX-32 4509
10 GRAPHIC g16842meridianlogo.jpg GRAPHIC 12302
  Complete submission text file 0001193125-20-212537.txt   9107661

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vivo-20200630.xsd EX-101.SCH 47851
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vivo-20200630_cal.xml EX-101.CAL 55922
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vivo-20200630_def.xml EX-101.DEF 267341
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE vivo-20200630_lab.xml EX-101.LAB 405093
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vivo-20200630_pre.xml EX-101.PRE 362894
11 EXTRACTED XBRL INSTANCE DOCUMENT d16842d10q_htm.xml XML 2145907
Mailing Address 3471 RIVER HILLS DRIVE CINCINNATI OH 45244
Business Address 3471 RIVER HILLS DR CINCINNATI OH 45244 5132713700
MERIDIAN BIOSCIENCE INC (Filer) CIK: 0000794172 (see all company filings)

IRS No.: 310888197 | State of Incorp.: OH | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-14902 | Film No.: 201083816
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences